Tilak Healthcare Raises 10 Million to Continue Growing Its Leading ... - Silicon Canals
| 4LL Stock | EUR 9.02 0.34 3.92% |
Roughly 55% of Teladoc's stockholders are presently thinking to get in. The analysis of current outlook of investing in Teladoc suggests that some traders are interested regarding Teladoc's prospects. The current market sentiment, together with Teladoc's historical and current headlines, can help investors time the market. In addition, many technical investors use Teladoc stock news signals to limit their universe of possible portfolio assets.
Teladoc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teladoc daily returns and investor perception about the current price of Teladoc as well as its diversification or hedging effects on your existing portfolios.
Teladoc |
Tilak Healthcare Raises 10 Million to Continue Growing Its Leading ... Silicon Canals
Read at news.google.com
 |
Teladoc Fundamental Analysis
We analyze Teladoc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teladoc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teladoc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Teladoc is rated fourth in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Teladoc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teladoc stock to make a market-neutral strategy. Peer analysis of Teladoc could also be used in its relative valuation, which is a method of valuing Teladoc by comparing valuation metrics with similar companies.
Peers
Teladoc Related Equities
| 4LL | Teladoc | 3.92 | ||||
| 9EH | Evolent Health | 3.88 | ||||
| 2HE | Healthequity | 1.69 | ||||
| COPA | COMPUGROUP MEDSPADR | 0.97 | ||||
| 1KJ | 10X GENOMICS | 0.56 | ||||
| COP | CompuGroup Medical | 0.28 | ||||
| 3CM | RLX TECH | 0.54 | ||||
| COP | Compugroup Medical | 0.64 | ||||
| VEE | Veeva Systems | 2.16 | ||||
| 1XZ | Ping An | 2.60 |
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |